MICL controls inflammation in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 75, Issue 7, 2016, Pages 1386-1391

  Redelinghuys, Pierre ^a   Whitehead, Lauren ^a   Augello, Andrea ^a   Drummond, Rebecca A ^a   Levesque, Jean Michel ^b   Vautier, Simon ^a   Reid, Delyth M ^a   Kerscher, Bernhard ^a   Taylor, Julie A ^a   Nigrovic, Peter A ^c   Wright, John ^c   Murray, Graeme I ^d   Willment, Janet A ^a   Hocking, Lynne J ^a   Fernandes, Maria J G ^b   DeBari, Cosimo ^a   Mcinnes, Iain B ^e   Brown, Gordon D ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITÉ LAVAL   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; COLLAGEN ANTIBODY; LECTIN RECEPTOR; PROTEIN CLEC12A; PROTEIN MICL; UNCLASSIFIED DRUG; CLEC12A PROTEIN, HUMAN; CLEC12A PROTEIN, MOUSE; LECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL ACTIVATION; CHIMERA; COLLAGEN ANTIBODY-INDUCED ARTHRITIS; CONTROLLED STUDY; DISEASE COURSE; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; IRRADIATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE; ANIMAL; ARTHRITIS, RHEUMATOID; BLOOD; DEFICIENCY; EXPERIMENTAL ARTHRITIS; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SYNOVIUM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LECTINS, C-TYPE; MICE; MYELOID CELLS; POLYMORPHISM, GENETIC; RECEPTORS, MITOGEN; SYNOVIAL MEMBRANE;

EID: 84940182848     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206644     Document Type: Article

References (24)

1. Sancho D, Reis E Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 2012;30:491-529.
2. Redelinghuys P, Brown GD. Inhibitory C-type lectin receptors in myeloid cells. Immunol Lett 2011;136:1-12.
3. Lorentzen JC, Flornes L, Eklow C, et al. Association of arthritis with a gene complex encoding C-type lectin-like receptors. Arthritis Rheum 2007;56:2620-32.
4. Flornes LM, Bryceson YT, Spurkland A, et al. Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex. Immunogenetics 2004;56:506-17.
5. Guo J, Wu X, Too CL, et al. A replication study confirms the association of dendritic cell immunoreceptor (DCIR) polymorphisms with ACPA-negative RA in a large Asian cohort. PLoS ONE 2012;7:e41228.
6. Marshall AS, Willment JA, Pyz E, et al. Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation. Eur J Immunol 2006;36:2159-69.
7. Pyz E, Huysamen C, Marshall AS, et al. Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand. Eur J Immunol 2008;38:1157-63.
8. Neumann K, Castineiras-Vilarino M, Hockendorf U, et al. Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell death. Immunity 2014;40:389-99.
9. Marshall AS, Willment JA, Lin HH, et al. Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes. J Biol Chem 2004;279:14792-802.
10. Chen CH, Floyd H, Olson NE, et al. Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production. Blood 2006;107:1459-67.
11. Gagne V, Marois L, Levesque JM, et al. Modulation of monosodium urate crystal-induced responses in neutrophils by the myeloid inhibitory C-type lectin-like receptor: potential therapeutic implications. Arthritis Res Ther 2013;15:R73.
12. Michou L, Cornelis F, Levesque JM, et al. A genetic association study of the CLEC12A gene in rheumatoid arthritis. Joint Bone Spine 2012;79:451-6.
13. Galligan CL, Baig E, Bykerk V, et al. Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity. Genes Immun 2007;8:480-91.
14. Taylor PR, Brown GD, Geldhof AB, et al. Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur J Immunol 2003;33:2090-7.
15. Dennehy KM, Ferwerda G, Faro-Trindade I, et al. Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol 2008;38:500-6.
16. Vautier S, Drummond RA, Redelinghuys P, et al. Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract. Infect Immun 2012;80:4216-22.
17. Graham LM, Tsoni SV, Willment JA, et al. Soluble Dectin-1 as a tool to detect beta-glucans. J Immunol Methods 2006;314:164-9.
18. Fujikado N, Saijo S, Yonezawa T, et al. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat Med 2008;14:176-80.
19. Lahoud MH, Proietto AI, Ahmet F, et al. The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses. J Immunol 2009;182:7587-94.
20. Nandakumar KS, Holmdahl R. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. J Immunol Methods 2005;304:126-36.
21. Wellcome Trust Case Control C. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007;447:661-78.
22. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19.
23. Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2013;506:376-81.
24. Harre U, Georgess D, Bang H, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012;122:1791-802.